Donate
Join Us

Articles

neurogene_website_banner_1500x700
April 18, 2023
Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community
webinar_news_article_hero_1500_x_700_px
April 12, 2023
An Update on the New Rett Digital Natural History Study: How Our Children’s Medical Records Created a Decades-Long Study in Months
daybue-key-facts-banner
March 23, 2023
DAYBUE (trofinetide): Key Facts for Parents
copy_of_news-family-_horiz
March 20, 2023
Fundraising in Small Town, USA
copy_of_news-researcher-_magenta_l
March 13, 2023
Cures for Many Rare Disorders Will Come More Quickly Because of Digital Natural History Studies
copy_of_blog_banner_-_template
March 7, 2023
Using Cerebral Organoids to Develop MECP2-Activating Drugs for Rett Syndrome
blog_banner_-_template
March 6, 2023
Remembering Michael R. Green (1954-2023): An eminent biologist who broke the monotony of mammalian transcription
copy_of_news-researcher-_blue_r
March 3, 2023
What Wearables and AI Can Tell Us About Rett Syndrome Severity
researcher_liu_mecp2_reactivation
February 9, 2023
New Study Demonstrates MECP2 Reactivation
hero-taysha-gene-therapies-shares-letter-to-the-rett-syndrome-community-1
February 1, 2023
Taysha Provides Update For Their Rett Syndrome Gene Replacement Program
neurogene-2023-news-banner
January 23, 2023
Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome
mini-mecp2-banner
January 10, 2023
The Story Behind Mini-MeCP2
2022-accomplishments-newsbanner
December 19, 2022
What We Accomplished in 2022
company_update_-_hero_for_blog_1
December 13, 2022
What We Learned from Taysha’s Clinical Trial Community Update
copy_of_lab_-_hero_for_blog_1
December 12, 2022
How You Can Take Action for Rett Research: The Only Wrong Way To Do It Is To Not Do It
lab_-_hero_for_blog
December 7, 2022
Why Biosensors Will Revolutionize How Treatments Are Evaluated
lab_-_hero_for_blog_1
December 5, 2022
The Most Important Research Factor: You
bloghdr-gtc-new
November 29, 2022
Leading the Cure for Rett: In Gene Replacement, There’s No Replacement for RSRT
$40M
Take Action